keptrohy glp-1 activation Unlocking the multifaceted roles of GLP-1: Physiological functions and therapeutic potential Suplemento Keptrohy Glp-1 Activation 60

Hepatology 68 , 252A (2018)

ACHIEVE-2: Up to 1.7% A1C reduction vs 0.8% with dapagliflozin (SGLT-2 inhibitor) ACHIEVE-5: Additional 2.1% A1C reduction when combined with insulin glargine Plus improvements in weight and cardiovascular risk factors Whats exciting is that this is a once-daily oral GLP-1 potentially expanding access to the same benefits seen with injectables like semaglutide

Our retrospective cohort study showed results consistent with Uedas work, indicating that GLP-1RAs were not associated with a significant risk of intestinal obstruction compared to SGLT2 inhibitors

Accordingly, we propose a vital, gold-standard methodology for both sample collection, processing, and storage of plasma used for glutathione quantification and for summary calculations of glutathione that can be used preclinically and clinically, thus yielding more streamlined translation

A.TriantafyllouG.DincerF.FilippaiosA.KoB

da Silva et al., 2021)